With the stimulation of 17β-estradiol, ERβ promotes the differentiation of Treg, which dominates the secretion of IL-10 as well as TGF-beta and down-regulate the activity of CD8+ T cell, causing the suppression of T cell-induced tumor immunocytotoxicity [87, 88]. The gene discussed is ESR2; the disease is neoplasm.